Cardiopulmonary Stress Testing Systems Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

The global Cardiopulmonary Stress Testing Systems market size surpassed US$ 4.6 Bn in 2019 and expected to reach US$ 7.7 billiob by 2027 with a CAGR of 6% from 2020 to 2027.

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. It is a non-invasive and highly sensitive stress test that evaluates the response of cardiovascular, pulmonary, neurophysiological, hematopoietic, and skeletal muscle systems to exercise. CPST plays an important role in the detection of ischemic heart disease, heart failure, shortness of breath, asthma, and other pulmonary disorders.

The primary goal of cardiac stress testing is to identify the risk stratification of coronary artery disease (CAD), which is one of the most common causes of deaths globally. It is a progressive condition that leads to the obstruction of blood vessels in the arteries providing blood to the heart muscles.

North America dominated the global cardiopulmonary stress testing systems market in 2018 and the trend is anticipated to continue during the forecast period. Continued adoption of cardiac monitoring equipment, presence of leading manufacturers of cardiac systems and rising prevalence of coronary artery diseases are expected to drive the market in North America.

Asia Pacific is likely to be a highly lucrative market for cardiopulmonary stress testing systems and it is expected to expand at a high CAGR during the forecast period owing to increasing disposable income, rise in geriatric population, and rising number of patients diagnosed with cardiovascular diseases and increase in adoption of advanced diagnosis & monitoring devices.

Rise in Geriatric Population to Drive Market

• There has been an unprecedented growth in the global geriatric population. According to the World Health Organization (WHO), people above the age of 65 years form the fastest growing population segment globally. The percentage of the population above 60 years of age across the globe is projected to double from 11% to 22% between 2000 and 2050. It also stated that 80% of older people will be living in low- and middle-income countries in 2050.
• Moreover, the global geriatric population would grow at the fastest rate in developed countries such as the U.S., the U.K., and Japan. Brazil, China, Thailand, and South Korea are expected to have a large geriatric population in a short span of time in the near future.
• Therefore, increase in geriatric population thereby increases the risk of coronary artery disease as this group of individuals are prone to cardiac disorders due to high total serum cholesterol levels.
• According to the article published by the National Center for Biotechnology Information) NCBI, Coronary artery disease accounts for 82% deaths in people aged 65 years and above. The prevalence rate of coronary heart disease in the U.S. is likely to increase by 26% between 2010 and 2040.

CPET Systems Segment to Dominate Market

• Based on type, the global cardiopulmonary stress testing systems market has been divided into CPET systems, stress ECG, pulse oximeters, stress BP monitors and single-photon emission computed tomography (SPECT). The CEPT system segment has been bifurcated into stationary and portable. The CPET systems segment dominated the global cardiopulmonary stress testing systems market in 2018 and the trend is projected to continue during the forecast period. Rapid adoption of CPET among professional athletes and technological enhancement in testing equipment to accelerate the growth of the segment.

North America to Dominate Global Market

• In terms of region, the global cardiopulmonary stress testing systems market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cardiopulmonary stress testing systems market in 2018, followed by Europe.
• North America accounted for major share of the global Cardiopulmonary Stress Testing Systems market in 2018. Availability of cardiac care facilities, increase in investment supporting medical treatment, and rising prevalence of cardiovascular diseases are expected to drive the growth of the market in the region. According to the Centers for Disease Control and Prevention (CDC), one in every four deaths in U.S. is due to heart disease. Coronary heart disease is the most common type of heart disease that accounts for nearly 370,000 deaths in the U.S. each year

Competitive Landscape

• The global cardiopulmonary stress testing systems market is fragmented in terms of number of players. Key players in the global market include General Electric Company, Koninklijke Philips N.V., CareFusion Corporation (BD), Spacelabs Healthcare (OSI Systems, Inc.), COSMED srl, MGC Diagnostic Corporation, Nihon Kohden Corporation, Schiller AG, SunTech Medical, Inc. and Welch Allyn among others

The global cardiopulmonary stress testing systems market has been segmented as follows:

By Type

• • CPET Systems
  • Stationary
  • Portable
  • Stress ECG
  • Pulse Oximeters
  • Stress BP Monitors
  • Single-Photon Emission Computed Tomography (SPECT)

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific          
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global cardiopulmonary stress testing systems market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2027. The report provides revenue of the global cardiopulmonary stress testing systems market for the period 2017–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global cardiopulmonary stress testing systems market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global cardiopulmonary stress testing systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global cardiopulmonary stress testing systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global cardiopulmonary stress testing systems market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global cardiopulmonary stress testing systems market.

The report delves into the competitive landscape of the global cardiopulmonary stress testing systems market. Key players operating in the global cardiopulmonary stress testing systems market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global cardiopulmonary stress testing systems market that have been profiled in this report.

Key Questions Answered in Global Cardiopulmonary Stress Testing Systems Market Report

• What is the scope of growth of product companies in the global cardiopulmonary stress testing systems market?
• What will be the Y-o-Y growth of the global cardiopulmonary stress testing systems market between 2019 and 2027?
• What is the influence of changing trends in technologies on the global cardiopulmonary stress testing systems market?
• Will North America continue to be the most profitable market for cardiopulmonary stress testing systems providers?
• Which factors are anticipated to hamper the growth of the global cardiopulmonary stress testing systems market during the forecast period?
• Which are the leading companies in the global cardiopulmonary stress testing systems market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global cardiopulmonary stress testing systems market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global cardiopulmonary stress testing systems market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the cardiopulmonary stress testing systems market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the cardiopulmonary stress testing systems market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global cardiopulmonary stress testing systems market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global cardiopulmonary stress testing systems market more reliably and accurately.

Table of Contents

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiopulmonary Stress Testing Systems Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe

    5.2. Pricing Analysis

    5.3. Epidemiology of Coronary Artery Disease, by Key Countries

6. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Product Type, 2017–2027

        6.2.1. CPET Systems

            6.2.1.1. Stationary

            6.2.1.2. Portable

        6.2.2. Stress ECG

        6.2.3. Pulse Oximeters

        6.2.4. Stress BP Monitors

        6.2.5. Single-Photon Emission Computed Tomography (SPECT)

    6.3. Global Cardiopulmonary Stress Testing Systems Market Attractiveness, by Product Type

7. Global Cardiopulmonary Stress Testing Systems Market Analysis and Forecast, by Region

    7.1. Key Findings

    7.2. Global Cardiopulmonary Stress Testing Systems Market Value Forecast, by Region

        7.2.1. North America

        7.2.2. Europe

        7.2.3. Asia Pacific

        7.2.4. Latin America

        7.2.5. Middle East & Africa

    7.3. North America Cardiopulmonary Stress Testing Systems Market Attractiveness, by Region

8. North America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Key Findings

    8.2. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        8.2.1. CPET Systems

            8.2.1.1. Stationary

            8.2.1.2. Portable

        8.2.2. Stress ECG

        8.2.3. Pulse Oximeters

        8.2.4. Stress BP Monitors

        8.2.5. Single-Photon Emission Computed Tomography (SPECT)

    8.3. North America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country, 2017–2027

        8.3.1. U.S.

        8.3.2. Canada

    8.4. North America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        8.4.1. By Product Type

        8.4.2. By Country

9. Europe Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        9.2.1. CPET Systems

            9.2.1.1. Stationary

            9.2.1.2. Portable

        9.2.2. Stress ECG

        9.2.3. Pulse Oximeters

        9.2.4. Stress BP Monitors

        9.2.5. Single-Photon Emission Computed Tomography (SPECT)

    9.3. Europe Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        9.3.1. Germany

        9.3.2. U.K.

        9.3.3. France

        9.3.4. Spain

        9.3.5. Italy

        9.3.6. Rest of Europe

    9.4. Europe Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        9.4.1. By Product Type

        9.4.2. By Country/Sub-region

10. Asia Pacific Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        10.2.1. CPET Systems

            10.2.1.1. Stationary

            10.2.1.2. Portable

        10.2.2. Stress ECG

        10.2.3. Pulse Oximeters

        10.2.4. Stress BP Monitors

        10.2.5. Single-Photon Emission Computed Tomography (SPECT)

    10.3. Asia Pacific Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.3.1. China

        10.3.2. Japan

        10.3.3. India

        10.3.4. Australia & New Zealand

        10.3.5. Rest of Asia Pacific

    10.4. Asia Pacific Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        10.4.1. By Product Type

        10.4.2. By Country/Sub-region

11. Latin America Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        11.2.1. CPET Systems

            11.2.1.1. Stationary

            11.2.1.2. Portable

        11.2.2. Stress ECG

        11.2.3. Pulse Oximeters

        11.2.4. Stress BP Monitors

        11.2.5. Single-Photon Emission Computed Tomography (SPECT)

    11.3. Latin America Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.3.1. Brazil

        11.3.2. Mexico

        11.3.3. Rest of Latin America Latin America

    11.4. Latin America Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        11.4.1. By Product Type

        11.4.2. By Country/Sub-region

12. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

        12.2.1. CPET Systems

            12.2.1.1. Stationary

            12.2.1.2. Portable

        12.2.2. Stress ECG

        12.2.3. Pulse Oximeters

        12.2.4. Stress BP Monitors

        12.2.5. Single-Photon Emission Computed Tomography (SPECT)

    12.3. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.3.1. GCC Countries

        12.3.2. South Africa

        12.3.3. Rest of Middle East & Africa

    12.4. Middle East & Africa Cardiopulmonary Stress Testing Systems Market Attractiveness Analysis

        12.4.1. By Product Type

        12.4.2. By Country/Sub-region

13. Competition Landscape

    13.1. Market Player - Competition Matrix (by Tier and Size of companies)

    13.2. Market Share / Position Analysis, by Company, 2018

    13.3. Company Profiles

        13.3.1. General Electric Company

            13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.1.2. Financial Overview

            13.3.1.3. Strategic Overview

            13.3.1.4. SWOT Analysis

        13.3.2. Koninklijke Philips N.V.

            13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.2.2. Financial Overview

            13.3.2.3. Strategic Overview

            13.3.2.4. SWOT Analysis

        13.3.3. CareFusion Corporation (BD)

            13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.3.2. Financial Overview

            13.3.3.3. Strategic Overview

            13.3.3.4. SWOT Analysis

        13.3.4. Spacelabs Healthcare (OSI Systems, Inc.)

            13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.4.2. Financial Overview

            13.3.4.3. Strategic Overview

            13.3.4.4. SWOT Analysis

        13.3.5. COSMED srl

            13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.5.2. Financial Overview

            13.3.5.3. Strategic Overview

            13.3.5.4. SWOT Analysis

        13.3.6. MGC Diagnostic Corporation

            13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.6.2. Financial Overview

            13.3.6.3. Strategic Overview

            13.3.6.4. SWOT Analysis

        13.3.7. Nihon Kohden Corporation

            13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.7.2. Financial Overview

            13.3.7.3. Strategic Overview

            13.3.7.4. SWOT Analysis

        13.3.8. Schiller AG

            13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.8.2. Financial Overview

            13.3.8.3. Strategic Overview

            13.3.8.4. SWOT Analysis

        13.3.9. SunTech Medical, Inc.

            13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.9.2. Financial Overview

            13.3.9.3. Strategic Overview

            13.3.9.4. SWOT Analysis

        13.3.10. Welch Allyn

            13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            13.3.10.2. Financial Overview

            13.3.10.3. Strategic Overview

            13.3.10.4. SWOT Analysis